It is worth mentioning that by using QNZ (an NF-κB inhibitor) the hyperglycemia-induced downregulation of AR was blocked, thus underlining the central role of NF-κB in preventing the development of PCa in T2D. The gene discussed is AR; the disease is Hyperglycemia.